# AnnHelene Ljungström

> AnnHelene Ljungström is a Series A investor backing Medical and Biopharma. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Total investments: 2
- Last investment: Jan 2025
- Lead investor: 0%
- Last updated: Aug 2026

AnnHelene Ljungström is a Series A investor focused on Medical and Biopharma. AnnHelene Ljungström

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Biopharma | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Debt Financing | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AnaCardio | AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure. | $18.4M | Series A | Jan 09, 2025 |  |
| AnaCardio | AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure. | $3.6M | Debt Financing | Feb 03, 2022 |  |

2 of 2 investments shown.

## Co-investors
- [Flerie Invest](https://shizune.co/investors/profile/flerie-invest) — VC Fund, 1 deal together
- [Industrifonden](https://shizune.co/investors/profile/industrifonden) — VC Fund, 1 deal together
- [Karolinska](https://shizune.co/investors/profile/karolinska) — VC Fund, 1 deal together
- [Novo Holdings](https://shizune.co/investors/profile/novo-a-s) — VC Fund, 1 deal together
- [Nybohov Invest](https://shizune.co/investors/profile/nybohov-invest) — VC Fund, 1 deal together
- [Pureos Bioventures](https://shizune.co/investors/profile/pureos-bioventures) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Chalmers Ventures AB](https://shizune.co/investors/profile/chalmers-ventures) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund

## Featured in investor lists
- [Medical Angel Investors in Sweden](https://shizune.co/investors/medical-angel-investors-sweden)
- [Biotech Angel Investors in Sweden](https://shizune.co/investors/biotech-angel-investors-sweden)

## FAQ

### What does AnnHelene Ljungström invest in?

AnnHelene Ljungström invests primarily in Medical and Biopharma startups, most often at Series A and Debt Financing stage. Most of the 2 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did AnnHelene Ljungström last invest?

The most recent investment recorded for AnnHelene Ljungström closed in Jan 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co